Refine by
Motor Skill Articles & Analysis
12 news found
Summary SurgiTel’s hybrid loupes incorporate our patented suspended magnification technology by positioning magnification oculars at the lowest point within a rimless bottom frame. This strategic placement, combined with the pantoscopic tilt of our lenses, creates an ergonomic loupe with a steep declination angle that is comparable to a deflection loupe (see Figure 4). The suspended ...
Clinical data demonstrating initial safety and efficacy from the RESKUE trial are being presented by Chief Medical Officer Maria Escolar, M.D., at the 29th Congress of European Society of Gene & Cell Therapy (ESGCT), October 11-14, 2022 Subjects treated with FBX-101 have shown increased galactocerebrosidase (GALC) enzyme activity in plasma and cerebrospinal fluid (CSF), normal white matter ...
Pisa, Italy-September 7, 2022 - Medical Microinstruments. Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. The new supermicro needle holder and ...
Neurolutions CSO and Founder Dr. Eric Leuthardt has contributed to two recently published studies showing proof that brain-computer interface therapy with the IpsiHand benefits the brain's motor networks and also motor recovery in chronic stroke patients with extended usage. Brain-Computer Interface – The Future of Rehabilitation Brain-computer interface rehabilitation using the IpsiHand ...
With the update 2.0 of the virtual reality therapy system CUREO® of the med-tech company CUREosity from Düsseldorf, therapy is optimized with intuitive, digital and efficient tools. Based on user analysis and evaluation of feedback from clinics, therapists and patients, we have further developed our system to relieve therapists. The update has been officially available since January 31. ...
Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces that it has been granted Breakthrough Designation by the U.S. Food and Drug Administration (“FDA”) for its Neuro-Motor PenTM (“NMP”) device. Breakthrough Designation has been granted for the proposed indication of using the ...
Manus Neurodynamica Limited (“Manus”), who develop and market products and technologies for neuromotor assessment, will be joining the ABHI UK Pavilion at MEDICA 2021 (15 – 18 November 2021) to launch their revolutionary non-invasive technology that supports an earlier and more accurate diagnosis of dementias and cognitive impairment. The NeuroMotor Pen (NMP) is a unique, ...
Experience our innovative virtual reality (VR) therapy system CUREO live at the MEDICA, November 15-18, 2021. We will be at the NRW booth in hall 3, booth number C80. We will also give presentations and talk about the advantages that come with virtual reality-based therapy Come by and check out live demonstrations of our smart therapy system that supports cognitive and sensorimotor ...
ORLANDO, FL – May 26, 2021 – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTCMKTS: AVMR) today announces that its Chief Medical Officer, Farhan Taghizadeh, MD will reveal the latest developments in the field of digital surgery at the prestigious 13th 5CC World Congress to be held virtually in Barcelona this September 2021. Dr. Taghizadeh is currently ...
Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, has received £600,000 grant funding from Innovate UK, to optimise and validate the NeuroMotor PenTM (NMP) for screening of dementias and cognitive impairment, over a two-year project. Only around 68% of over 65s, estimated to have dementia have been diagnosed. ...
Gesynta Pharma AB today announced that the first patients have been dosed in a Phase II study of its oral drug candidate GS-248 in patients with systemic sclerosis - a debilitating autoimmune disease that causes serious damage to the microvasculature. This proof-of-concept study will investigate the safety of GS-248 and its efficacy on Raynaud's phenomenon and peripheral blood flow in this ...
SEATTLE – Oct. 5, 2015 – Today Cadence Biomedical, maker of Kickstart®, which helps people with neurological conditions recover to walking, announced a new research collaboration with the University of Nebraska Omaha (UNO) to study stroke survivors’ ability to adapt and improve motor skills after using the Kickstart device. Dr. Mukul Mukherjee, assistant professor at UNO and ...